Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensCell Lines for BBB Modeling
- Immortalized Cells for BBB ModelingPrimary Cells for BBB ModelingStem Cells for BBB ModelingProteins & Peptides for Stroke ResearchOnline Inquiry
Human VAMP2 ELISA Kit (AC2605)
Cat.#: ASET-1194
Specifications
Description Human VAMP2 ELISA Kit, a 90-minute assay kit, allows for the in vitro quantitative determination of human VAMP2 concentrations in serum, plasma, and other biological fluids. Size 96T Sample Type Serum, plasma or other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 8.36 ng/L Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 100-1600 ng/L Assay Time ~90 min Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-2494 Rat Inhibin beta B ELISA Kit (AC3905) Quantitative inquiry ASET-2463 Human Syntenin ELISA Kit (AC3874) Quantitative inquiry ASET-2340 Mouse alpha MSH ELISA Kit (AC3751) Quantitative inquiry ASET-1255 Rat nNOS (neuronal) ELISA Kit (AC2666) Quantitative inquiry ASET-1495 Mouse Dopamine Receptor D1 ELISA Kit (AC2906) Quantitative inquiry ASET-1882 Human ERK1 ELISA Kit (AC3293) Quantitative inquiry ASET-2244 Human Big Dynorphin ELISA Kit (AC3655) Quantitative inquiry ASET-1176 Human CD97 ELISA Kit (AC2587) Quantitative inquiry ASET-1825 Mouse NRG4 ELISA Kit (AC3236) Quantitative inquiry ASET-2065 Human FLJ39155 ELISA Kit (AC3476) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket